Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Market Cap

Lexaria Bioscience has a market cap or net worth of $18.47 million as of March 27, 2026. Its market cap has decreased by -20.37% in one year.

• Market Cap: 18.47M
• Enterprise Value: 14.15M
• 1-Year Change: -20.37%
• Ranking: #4960
• Category: Nano-Cap
• Stock Price: $0.74

Market Cap Chart

Since February 12, 2007, Lexaria Bioscience's market cap has decreased from $19.40M to $18.47M, a decrease of -4.77%. That is a compound annual growth rate of -0.26%.

Market Cap History

Date	Market Cap	% Change
Mar 27, 2026	18.50M	35.04%
Dec 31, 2025	13.70M	-62.67%
Dec 31, 2024	36.70M	186.72%
Dec 29, 2023	12.80M	-12.33%
Dec 30, 2022	14.60M	-36.80%
Dec 31, 2021	23.10M	2.67%
Dec 31, 2020	22.50M	-24.75%
Dec 31, 2019	29.90M	-58.30%
Dec 31, 2018	71.70M	-38.87%
Dec 29, 2017	117.30M	624.07%
Dec 30, 2016	16.20M	131.43%
Dec 31, 2015	7.00M	125.81%
Dec 31, 2014	3.10M	342.86%
Dec 31, 2013	700.00K	-12.50%
Dec 31, 2012	800.00K	-77.78%
Dec 30, 2011	3.60M	-7.69%
Dec 31, 2010	3.90M	69.57%
Dec 31, 2009	2.30M	130.00%
Dec 31, 2008	1.00M	-94.71%
Dec 31, 2007	18.90M	-2.58%
Feb 12, 2007	19.40M	-

View and export this data all the way back to 2007. Sign Up Today.

Related Stocks

Company	Market Cap
Passage Bio	20.47M
NanoViricides	19.58M
VYNE Therapeutics	19.54M
Polyrizon	19.30M
Skye Bioscience	19.26M
Lixte Biotechnology Holdings	17.63M
Outlook Therapeutics	17.29M
Pasithea Therapeutics	17.09M